Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

NAActive, not recruitingINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

July 16, 2026

Study Completion Date

July 16, 2026

Conditions
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Interventions
PROCEDURE

Echocardiogram Recording

Undergo assessment via echo

OTHER

Questionnaire Administration

Ancillary Studies

PROCEDURE

Stress Cardiac Magnetic Resonance Imaging

Undergo assessment via CMR

DEVICE

Wireless Synchronized Cardiac Function Monitoring Device

SphygmoCor® Xcel Oscar 2™ Ambulatory Blood Pressure Monitor

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER